1. Market Research
  2. > Cancer Industry

Leukemia Industry, July 2016 Market Reports from Top Publishers

You might be interested in: Molecular Diagnostic, Diagnostics, Cancer, Therapy, Blood Disease, Bone Marrow Transplant, Pap Smear, Blood Supply, Cancer Diagnostic, Clinical Trial, Anti-Infective, In Vitro Diagnostic Reagent, Stem Cell.


 
1-10 of about 300 reports for Leukemia

Purchase Reports From Reputable Market Research Publishers

B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016

B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016" provides ...

Global Leukemia Partnering 2010 to 2016

Global Leukemia Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • July 2016
  • by Currentpartnering

Provides understanding and access to the leukemia partnering deals and agreements entered into by the worlds leading healthcare companies . The Global Therapy Partnering Terms and Agreements since 2010 ...

Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016

Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • July 2016
  • by Currentpartnering

Provides understanding and access to the acute and chronic myelogenous leukemia partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Therapy Partnering Terms ...

Health Discovery Corporation (HDVY) - Product Pipeline Analysis, 2016 Update

Health Discovery Corporation (HDVY) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • June 2016
  • by Global Data

Summary Health Discovery Corporation (HDC) is a biotechnology company that offers medicine and biomarker discovery services. The company’s products comprise support vector machine, recursive feature ...

Acute Promyelocytic Leukemia Global Clinical Trials Review, H1, 2016

Acute Promyelocytic Leukemia Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Acute Promyelocytic Leukemia Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Acute Promyelocytic Leukemia Global Clinical Trials Review, H1, 2016" provides an overview ...

Neuroblastoma Global Clinical Trials Review, H1, 2016

Neuroblastoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Neuroblastoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Neuroblastoma Global Clinical Trials Review, H1, 2016" provides an overview of Neuroblastoma clinical ...

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) ...

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic ...

Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 (Bcl-2-Like Protein 3 or Bcl-2-Related Protein EAT/Mcl1) - Pipeline Review, H1 2016

Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 (Bcl-2-Like Protein 3 or Bcl-2-Related Protein EAT/Mcl1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 (Bcl-2-Like Protein 3 or Bcl-2-Related Protein EAT/Mcl1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Induced Myeloid Leukemia ...

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - ...

About 4 200 reports for Leukemia

Download Unlimited Documents from Trusted Public Sources

Blood Disease Statistics and Leukemia Statistics

  • January 2014
    265 pages
  • Blood Disease  

    Leukemia  

    Lymphoma  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.